Lipton RB, et al. Patient Global Impression of Change related to improvement in most bothersome symptom following treatment with eptinezumab. IHC-PO-167. IHC 2019, 5-8 sept. Dublin, Ierland.
1,5 miljoen euro voor onderzoek naar SCA1
jun 2019 | Neuro-musculair